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ABSTRACT 
Motivation: Molecular signatures for predicting breast cancer 
prognosis could greatly improve care through personalization of 
treatment.  Computational analyses of genome-wide expression 
datasets have identified such signatures, but these signatures leave 
much to be desired in terms of accuracy, reproducibility and 
biological interpretability.  Methods that take advantage of structured 
prior knowledge (e.g. protein interaction networks) show promise in 
helping to define better signatures but most knowledge remains 
unstructured. 
 
Crowdsourcing via scientific discovery games is an emerging 
methodology that has the potential to tap into human intelligence at 
scales and in modes previously unheard of.  Here, we developed 
and evaluated a game called “The Cure” on the task of gene 
selection for breast cancer survival prediction.  Our central 
hypothesis was that knowledge linking expression patterns of 
specific genes to breast cancer outcomes could be captured from 
game players.  We envisioned capturing knowledge both from the 
player’s prior experience and from their ability to interpret text 
related to candidate genes presented to them in the context of the 
game.   
 
Results:  Between its launch in Sept. 2012 and Sept. 2013, The 
Cure attracted more than 1,000 registered players who collectively 
played nearly 10,000 games.  Gene sets assembled through 
aggregation of the collected data clearly demonstrated the 
accumulation of relevant ‘expert’ knowledge.  In terms of predictive 
accuracy, these gene sets provided comparable performance to 
gene sets generated using other methods including those used in 
commercial tests.  The Cure is available at 
http://genegames.org/cure/ 
1 INTRODUCTION  
Breast cancer is the most common form of cancer in women (Bray, 
et al., 2013).  It has been studied extensively with genomic 
technologies, with many attempts to devise molecular predictors of 
clinical outcomes (Griffith, et al., 2013; Margolin, et al., 2013; van 
't Veer, et al., 2002) and drug response (Daemen, et al., 2013).  If 
successful, tests derived from these predictors would pave the way 
towards personalized therapy and better care.  While much 
progress has been made, including several commercially available 
  
*To whom correspondence should be addressed.  
tests (Ross, et al., 2008), molecular predictors consistently show 
lower than desirable accuracy, degrade in performance in 
subsequent validation studies, identify different gene sets in every 
permutation, and often have no discernable biological rationale 
(Weigelt, et al., 2012).   
 
Any attempt at class prediction based on high throughput (e.g. 
microarray) data is technically challenging because of the very 
large number of potential features (Cheng, et al., 2013b).  The 
individual members of optimal feature sets work synergistically, 
displaying relationships that make the group more useful for 
prediction as a whole than any individual unit.  The space of 
possible feature combinations is too large to explore exhaustively 
and, even if it were, the tests available for evaluating feature set 
quality are not precise.  As a result, researchers rely on heuristics 
and, increasingly, on prior knowledge to identify good feature 
groups. 
 
Recent gene selection methods are driven by structured prior 
knowledge in forms such as protein-protein interaction networks 
(Dutkowski and Ideker, 2011; Winter, et al., 2012), pathway 
databases (Bild, et al., 2006; Su, et al., 2009) and information 
gathered from pan-cancer datasets (Cheng, et al., 2013a).  These 
methods guide the search for predictive gene sets towards cohesive 
groups related to each other and to the predicted phenotype 
through biological mechanism.  In doing so, they have improved 
the stability of the gene selection process and the biological 
relevance of the identified signatures.  These techniques hint at the 
potential of strategies that marry a top-down approach based on 
established knowledge with a bottom-up approach based directly 
on experimental data, but they have not yet produced substantially 
greater accuracy than other approaches.  This may be due in part to 
a scarcity of relevant structured knowledge with which to compute. 
 
Since the year 2000, more than 164,000 publications related to 
breast cancer have been added to PubMed 
(http://tinyurl.com/brsince2000).  Within that body of literature 
and in the minds of those that have created and consumed it lays a 
wealth of knowledge relevant to selecting gene sets for survival 
prediction.  Here, we explore a crowdsourcing approach for 
tapping into that knowledge.   
 
Crowdsourcing processes take tasks traditionally performed by 
individuals or small groups and reformulate them such that large 
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numbers of people can participate in their completion.  There are 
many instantiations of the crowdsourcing paradigm (Good and Su, 
2013), here we focus on just one: games with a purpose (GWAP) 
(von Ahn and Dabbish, 2008).  GWAPs incentivize large-scale 
work by translating the required labor into elements of games.  The 
games are played for fun, for learning, and to aid in achieving the 
underlying purpose.  Popular GWAPs within biology include 
Foldit, for protein folding (Cooper, et al., 2010), Phylo for multiple 
sequence alignment (Kawrykow, et al., 2012) and MalariaSpot for 
image analysis (Luengo-Oroz, et al., 2012).  Here we introduce a 
GWAP for genomic feature selection called The Cure. 
 
Our high-level objective is to identify genes that can be used to 
build improved prognostic predictors for breast cancer.  Our 
hypothesis is that, if aggregated effectively, the collective 
knowledge, reading, and reasoning ability of a large community 
could help to identify genes that are useful in constructing robust 
classifiers but might be hidden from purely data-driven 
approaches.  In striving to achieve that aim, we conducted the 
study described here to assess the feasibility of the use of an open, 
online game (The Cure) in capturing pertinent, expert-level 
biomedical knowledge.      
 
The central questions addressed are: 
 
(1) How many people, of what levels of expertise, would play 
a game oriented around gene selection for breast cancer 
survival prediction and why? 
(2) Would it be possible to extract a gene ranking from the 
results of play that reflected biomedical knowledge?  That 
is, could the game act as a portal for expert-level 
knowledge transfer? 
(3) Could the gene ranking captured through the game be used 
to generate classifiers that perform well in cross-dataset 
evaluations? 
 
The null hypotheses are that (1) no one would play, (2) the results 
of their play would not yield discernible biological knowledge, and 
(3) any gene ranking produced would be no better than random.  
Below we discuss the design of the game and then present results 
from one year of open play that shed light on each of the questions 
posed above.   
2 GAME DESIGN 
The Cure is a web application consisting of the pages: home, login, 
board selection, game and help.  The home page provides 
information about the project and the game and allows users to 
either login or create accounts.   Users must create an account to 
play.  During account creation, users must select a username and 
password and have the option of entering an email address and 
answering three short survey questions: “Most recent academic 
degree?”, “Do you consider yourself knowledgeable about cancer 
biology?”, and “Do you consider yourself a biologist?”.   
 
Training 
When players first register, they are presented with a training stage 
that must be passed before they enter the main game area.  The 
training stage consists of four ‘boards’ containing 2 to 4 features 
common to animals such as “number of legs, breathes air, produces 
milk, etc.”.  To complete the level, the player must select the 
features that can best be used to discriminate between mammals 
and other classes of animal - before the games automated opponent 
‘Barney’ beats them to it.  This task was chosen as a way to 
introduce the dynamics of the game and to get across the idea of 
feature selection for classification on a straightforward problem.   
 
Game 
After training, the player is presented with boards containing 25 
different genes (Fig. 1).  The objective of each game is to choose a 
set of 5 genes that produces a better decision tree classifier than 
that of the automated opponent ‘Barney’.  The players alternate 
turns taking a gene card from the board and placing it in their hand, 
with the human player always going first.  Once a card is taken 
from the board, it cannot be put back and the other player cannot 
take it.  The score for the final 5-card hand determines the winner 
of the game.  Note that each time a board is rendered, the locations 
of the genes are randomized to prevent bias. 
  
 
 
Fig. 1. The Cure game.  Players alternate turns taking a gene card 
from the board and adding it to their hand.  The tabbed display 
provides gene annotations (‘ontology’, ‘Rifs’) and views of 
decision trees constructed by the system using the selected genes. 
 
Fig. 2. Gene Rifs tab showing information about the Dicer gene. 
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Gene annotations 
Mousing over each gene provides the player with information 
including: a summary description from Unigene, Gene Ontology 
annotations, and related Gene Rifs (Fig. 2).  All of the annotations 
contain hyperlinks that the players can follow for more 
information.  A search interface allows the player to find genes on 
the board based on the text in their related annotations.  Coupled 
with the player’s biological knowledge, this information helps the 
player make informed guessed about which genes from the board 
might make the most useful predictors. 
 
Scoring 
Each time a card is added to a player’s hand, the game server 
scores the hand by evaluating the combined predictive 
performance of the genes it contains.  To accomplish this 
evaluation, the server uses a gene expression dataset containing 
samples classified with long-term (>10 year) survival status.  In 
each evaluation, the server uses data from just the genes in the 
player’s hand to train and test a decision tree classifier.  The score 
for the hand is the accuracy returned by a cross-validation 
experiment.   In machine learning parlance, this is known as a 
“wrapper” feature set evaluation scheme (Kohavi and John, 
1997).  A simplified decision tree created using all of the available 
training instances but just the selected genes is displayed for the 
player and their opponent (Fig. 1).  If the player loses they are not 
awarded any points, they may play the board again or select a 
different board to play.  If they win, their score is determined based 
on the accuracy of their winning tree.  Within each round, player 
scores are cumulative.  The more games they win, the higher their 
score.  The player’s score is displayed on the board selection page 
along with its global rank and the current top 10 scores. 
 
Board selection 
Each round of The Cure consists of a collection of 100 different 
boards for players to choose from (Fig. 3).  Each board is 
composed of a different set of 25 genes (See Methods for board 
composition strategies).  The boards are arranged in loose order of 
difficulty with the easiest boards occupying the lower 
numbers.  Difficulty is assessed based on an estimation of the 
predictive power of the complete 25 gene set - the more predictive, 
the easier the board.  The goal of the board selection page is to 
capture both broad and deep coverage of all the boards (and their 
corresponding gene sets) by the player community.  Once a given 
board has been completed by at least 11 players, it is closed off so 
that players are forced to select a different board.  Any open board 
can be selected for play.  Also, once each player has completed a 
particular board, they are not allowed to play it again.     
 
Purpose 
The purpose of The Cure is to translate the knowledge of the 
players along with their ability to process textual information into a 
ranked list of genes for use in the development of predictors for 
breast cancer prognosis.  This translation is enacted when the 
players select genes in the game.  We record the gene selections 
and apply aggregation functions to produce gene rankings that 
reflect the consensus knowledge of the player community. 
 
3 RESULTS 
The results presented here are derived from games played between 
September 7, 2012 and September 5, 2013.  In that time 1077 
player accounts were created and a total of 15669 games were 
played (including training games).  9904 games were played on the 
cancer datasets.  
3.1 Players and Games Played 
Based on the self-reported data collected during registration, the 
player population was mixed in terms of education, orientation as a 
biologist, and declared knowledge of cancer.  In total, 35% of the 
players had a graduate degree, 29% had an undergraduate degree, 
and 36% did not declare any degree.  32% of players considered 
themselves biologists while 63% did not, with 5% not 
responding.  33% of players declared that they were 
knowledgeable about cancer biology, 60% did not, and 7% 
declined to respond.  
 
Over the course of the year, the number and demographics of 
players registering to play per month fluctuated (Fig. 4).  In the 
first two months, 36 and 37% of the players who registered had 
PhDs.  After those months, the percentage for the next four months 
dropped to around 15% and then fluctuated between 5 and 10% 
Fig. 3.  Board selection view.  Stars indicate boards the active 
player has completed, circles indicate boards that have been 
completed by a sufficient number of different players, and 
numbers indicate open boards.  The pink progress bar indicates 
how close the community is to finishing the board.  
 
Fig. 4.  New player registrations per month, with degree. 
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thereafter.  We observed two notable spikes in player 
registrations.  The first coincided with the launch of the game, its 
presentation at Genome Informatics 2012 and its advertisement as 
part of the Sage Bionetworks DREAM7 breast cancer prognosis 
challenge.  The second, in May of 2013, is likely related to a 
posting on the popular website i09 (http://io9.com/these-cool-
games-let-you-do-real-life-science-486173006) which occurred on 
May 1, 2013. 
 
The total number of games played roughly followed the trends 
observed for new player registrations.  The most games played on 
a single day was 550, on May 2, immediately after the i09 posting. 
 
The number of games played per player followed a power law 
consistent with most studies of the quantity of voluntary 
contributions in open environments (e.g. Wikipedia contributions) 
(Javanmardi, et al., 2009).  243 players played more than 10 
games, 28 players played more than 100 games and the most 
prolific player (‘oneoff64’) played 718 games (Fig. 5). 
3.2 Aggregation function for gene ranking 
Each time a player selects a gene in a game, they are indicating to 
the system their intuition of that gene’s relevance for predicting 
breast cancer survival.  That intuition may be based on their 
knowledge, on inferences drawn from gene annotation information 
or solely on random speculation.  By aggregating the data collected 
from many different players across many different games, we tried 
to eliminate the noise from random clicking and reveal the 
community consensus with regard to predictive genes.   
 
Given a set of recorded games, our gene ranking method is as 
follows.  For each gene g we estimate the frequency of selection 
F(g) as: 
 𝐹(𝑔) = 𝑆(𝑔)𝑂(𝑔) 
O(g) equals the number of times the gene g appeared in a played 
game.  Some genes appear on multiple boards, all boards are 
played by multiple players, all occurrences are counted.  S(g) is the 
number of times the gene was selected by the human player.   
 
We then empirically calculated a one-tailed p value for each value 
of F given O through simulations of random game play.  The p 
values indicate the chances of observing a value of S or greater 
given O assuming that all gene selections were random.  
Importantly, they allow for comparisons between genes with 
different numbers of occurrences.  For example, the known 
apoptosis regulator BCL2 gene occurred in 13 played games (O = 
13) and was selected in 10 of those games (S = 10), thus F for 
BCL2 was 0.77 with p < 0.0001.  Our simulations stopped at 
10,000 iterations per value of O, hence p values below 0.0001 
cannot be reported.  On the other end of the spectrum, the AARD 
gene (of unknown function) appeared in 33 played games (O = 33), 
was selected 3 times (S = 3), had an F of 0.09 with p = 0.91.  
Given any collection of played games, we generate gene rankings 
based on the estimated p values for each value of F.  We can thus 
assemble gene sets based on different groups of games as well as 
different p value cutoffs.   
 
3.3 Gene set evaluations 
We evaluated three game collections: ‘all’, ‘expert’, and 
‘inexperienced’.  ‘All’ considers games from all players, ‘expert’ 
includes games from players that indicated that they had either a 
Ph.D. or an M.D. and knowledge of cancer, and ‘inexperienced’ 
includes just the games played by people without an advanced 
degree, with no knowledge of cancer and that were not biologists.  
Only the first game per player per board is used for the analysis to 
reduce the chances of individual players essentially over-fitting the 
training data for a particular board.  Each game should reflect only 
the player’s thoughts about the best genes for that board prior to 
seeing the results of the decision tree analysis.    
 
For all the results reported here, we select genes with p <= 0.001.  
At that threshold, we observed 61 genes in the ‘all’ group, 85 in 
the ‘expert’ group and 13 in the ‘inexperienced’ group (Table 1).   
 
Table 1. Predictor gene sets derived from The Cure. 
 
Player group N genes,  
p < =0.001 
Games 
considered 
Contributing 
players 
All 61 4314 477 
Expert 85 1106 52 
Inexperienced 13 1643 231 
 
One gene, CASP1, appeared in all three sets. The ‘all’ gene set 
included 35 genes that also appeared in the expert set as well as 4 
genes from the inexperienced set (Fig. 6). Aside from CASP1, 
there was no overlap between the expert and inexperienced gene 
sets. 
Fig. 5. Games played per player. 
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Enrichment analysis of gene sets 
Given the gene sets identified above, the next question is whether 
or not they are relevant to breast cancer.  Has knowledge 
successfully been transferred from the player population into the 
game?   
 
Using WebGestalt (Wang, et al., 2013), we found both the ‘expert’ 
gene set and the ‘all’ gene sets to be significantly enriched for 
cancer-related diseases while the ‘inexperienced’ set was not 
significantly enriched for any diseases (Table 2).  The background 
genes used for the enrichment analysis statistics corresponded to 
the 3731 genes that appeared in at least one game.  The disease 
term with the most significant corrected p value in both the ‘all’ 
and ‘expert’ gene sets was ‘cancer or viral infections’.  All of the 
top ten disease terms for both gene sets correspond to various 
kinds of cancer or cancer processes such as ‘recurrence’ and 
‘disease progression’.  Though they do not appear in the top ten 
results, “Breast neoplasms’ and ‘Carcinoma, Ductal, Breast’ are 
significantly represented in both gene sets (p < e-05).   
 
Table 2.  The top ten most significantly enriched disease terms for 
the ‘expert’ gene set.  WebGestalt enrichment statistics are also 
shown for the ‘all’ gene set for the same terms. 
Expert players (85 genes) All (61 genes) 
Disease term Genes 
in set 
Adj.  
P value 
(BH) 
Genes 
in set 
Adj.  
P value 
(BH) 
Cancer or Viral 
Infections 
37 5.5e-16 25 8.1e-10 
Neoplasms 32 4.7e-13 22 1.6e-08 
Urogenital Neoplasms 23 2.7e-11 12 9.0e-05 
Cell Transformation, 
Neoplastic 
16 4.7e-11 13 3.0e-09 
Stomach Neoplasms 14 2.6e-08 8 2.0e-04 
Disease Progression 16 3.7e-08 13 2.5e-07 
Neoplastic Processes 20 5.1e-08 18 1.3e-08 
Recurrence 14 5.1e-08 11 1.1e-06 
Intestinal Neoplasms 15 6.1e-08 6 0.01 
Necrosis 15 1.1e-07 13 1.8e-07 
 
Comparison to established predictor gene sets 
In addition to the disease enrichment analysis, we measured the 
overlap between the game-derived gene sets and predictor gene 
sets used in commercial prognostic tests and from recent 
publications.  Figure 7 shows the overlaps between the expert 
game gene set, the 21 genes used in the OncotypeDx test (Paik, 
2007), the 70 genes in the Mammaprint test (van 't Veer, et al., 
2002), 100 genes recently identified via Random Forest analysis 
(RFRS) (Griffith, et al., 2013), and 94 genes recently identified via 
the Attractor Metagenes approach (Cheng, et al., 2013b).  Genes in 
the gold standard sets that never appeared in a played game were 
removed from the comparison. (e.g., only 58 of the 70 genes in the 
Mammaprint set were used.)  The ‘expert’ gene set contained four 
of the OncoType genes, zero of the Mammaprint genes, three of 
the RFRS genes and two of the Attractor Metagenes.  Based on a 
Fisher’s exact test, there was a statistically significant overlap with 
only the OncoType genes (p = 2.026E-4).   
 
Classifier evaluations 
The gene set comparisons and enrichment analyses described 
above show clearly that the gene sets generated from the game data 
are non-random with a significant representation of genes that are 
related to cancer.  The final question addressed here is how well 
the game-derived gene sets do when used to create classifiers for 
predicting breast cancer survival.    
 
We conducted two experiments, each involving the development 
of machine learning models for predicting 10-year survival based 
only on gene expression information.  In the first, we trained a 
support vector machine (SVM) classifier using gene expression 
data from the Metabric dataset (Curtis, et al., 2012) and tested it on 
the Oslo validation dataset generated for the Sage Dream7 breast 
cancer challenge (Margolin, et al., 2013).  In the second, we used 
the dataset from (Griffith, et al., 2013), using the same division of 
training/test data described in that publication.  In both cases, we 
varied only the gene sets provided to the classifiers and measured 
the performance of each gene set based on the accuracy of the 
SVM on the samples in the corresponding test set.  As shown in 
Figure 8, both the ‘expert’ and ‘all’ gene sets from the game 
performed comparably to the OncoType, Mammaprint, RFRS, 
Attractor MetaGenes, and to gene sets selected in an expert 
literature review (Lauss, et al., 2008).  In fact, the ‘expert’ gene set 
Fig. 6. Overlap of game-derived gene sets. 
 
Fig. 7. Overlap of ‘expert’ gene set derived from game data (in 
green) with prior published predictor gene sets. 
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from The Cure had the highest accuracy on the Griffith test set and 
the third highest accuracy on the Oslo test set.   
 
Based on these experiments and others employing different 
machine learning methods (data not reported) we could not 
establish a statistically significant difference between the 
performance of models trained using the game-derived gene sets 
versus models trained with gene sets from more established 
methodologies.  While we could not prove that the game-derived 
gene set was better than the other gene sets in a statistically 
significant manner, none of the other gene sets – including those 
used in commercial tests – were found to be consistently better 
either.  The lack of a clear ‘winner’ in this analysis reinforces the 
concept that there are actually many different gene sets whose 
expression signatures are nearly equally predictive of breast cancer 
prognosis (Venet, et al., 2011).  Identifying the optimal 
combination of genes, clinical features (e.g. age, lymph node 
status) and machine learning approach remains a future challenge. 
 
3.4 Player survey 
The Cure managed to attract and engage a surprisingly large 
number of people.  To ascertain more about the player population 
we conducted a survey of registered players as of November 2013.     
We sent an email to the 1162 players who had entered an email 
address when they registered inviting them to answer questions 
about themselves, their motivations for playing and their 
experience with the game.  We received responses from 119 
participants.  While the respondents represent only about 10% of 
the total player population (and likely a more motivated segment), 
the responses do provide some interesting insights.  
 
The first and perhaps most telling question in the survey was:  
“Why did you sign up for The Cure?”.  Overall, 71% indicated that 
they played to help breast cancer research, 52% played to learn 
something and just 44% played in order to have fun.  Respondents 
could select multiple answers.  Given the design of The Cure 
website (“Play Games, Cure Cancer!”) as well as the way it was 
promoted, it is surprising to see that the game aspect was actually 
the least motivational of the three.  While we feel that developing 
this system as a game had a strong positive effect on recruitment 
and engagement, its clear that there is a large pool of people that 
are highly motivated to contribute to breast cancer research in any 
way they can.  The game was simply one more vehicle through 
which they could try to help.  In some cases, this motivation is 
likely very personal; 64% of respondents indicated that they know 
or have known someone that has or has had breast cancer.   
 
Looking at the player demographics, we found that 59% of the 
respondents were male and 41% female.  The largest age brackets 
were 21-29 (34.5%) and 30-39 (28.6%) (Fig. 9).   
 
Expanding on the expertise information collected when players 
registered, we asked players to categorize their knowledge of 
breast cancer.  The most popular answer by a wide margin was the 
middle expertise level “I know some biology and have some 
understanding of what cancer is” at 57.1% with numbers 
decreasing towards the high and low expertise levels (Fig. 10).   
 
Finally we asked players whether the game was fun and whether or 
not they learned anything.  Most (66%) found the game to be “A 
Fig. 8. Evaluation of accuracy of models trained to predict ten-
year survival using gene sets derived from the game and prior 
gene sets from the breast cancer literature. 
 
Fig. 10. Levels of breast cancer knowledge among players. 
 
Fig. 9. Ages of players. 
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little bit entertaining”, 14% found it to be “very fun”, and 19% 
found it “not at all” fun.  The results for learning are similar, with 
62% feeling that they “learned a little bit”, 9% that they “learned a 
lot”, and 29% that they “did not learn thing”. 
 
In summary, the survey showed that The Cure reached a 
demographically diverse audience containing both experts and 
novices, that most players found the game mildly entertaining and 
educational, and that the dominant motivation for playing was to 
help breast cancer research.  
4 DISCUSSION 
The principal contribution of this work is to show that 
crowdsourcing games can be developed as a means to address 
problems that require expert-level knowledge.  While previous 
work on games such as Foldit and citizen science projects like 
Galaxy Zoo have focused on visual problems that do not require 
any knowledge on the part of the participant, the task presented in 
The Cure was knowledge intensive.  In order to successfully 
participate, players either had to bring significant prior experience 
or be willing to invest a substantial amount of time learning.  The 
numbers of players and games played provide evidence that there 
is a large audience of experienced and curious people that are 
willing to participate in knowledge and reasoning-intensive 
challenges.  The analysis of the gene sets produced from the 
aggregated data shows that the game successfully acted as a 
vehicle for capturing knowledge from this newly formed 
community.  While this game did not generate a better predictor of 
breast cancer prognosis, the results are in general very 
encouraging. 
 
Limitations 
The game described here was an early-stage prototype with many 
limitations in terms of both its ability to achieve its purpose and its 
ability to entertain players.  Chief among the former was that the 
pre-built boards severely constrained the number of different 
feature combinations that players could explore.  The vast majority 
of possible gene sets simply could never be examined within this 
game framework.  Further, because the aggregation function 
ranked individual genes rather than gene sets, it is unlikely that it 
would identify optimal feature combinations.  In future iterations, 
it would be beneficial to adapt the game to allow advanced players 
more freedom to explore the feature space while still maintaining 
the competitive dynamics that made the game entertaining.   In 
addition to providing greater room for exploration, the game could 
be made much more fun overall – especially for not-yet-expert 
players.  The current formulation was highly repetitive and had an 
extremely steep learning curve.  The transition from the brief 
training stage to the real games was abrupt and left many players 
confused.  In the future, both the fun factor and the learning 
aspects of the game could be improved by implementing different 
levels of difficulty, providing more educational information in the 
early stages, and diversifying the tasks presented to players.  The 
code for The Cure game is open source and we would warmly 
welcome any contributions or adaptations  
(https://bitbucket.org/sulab/thecure/).   
5 CONCLUSION 
There is a large, heterogeneous population of people on the 
Internet that actively seek ways to use their minds to help solve 
important problems.  Games such as The Cure provide one avenue 
to tap into this hidden resource for biomedical discovery. 
6 METHODS 
Composing gene sets for four rounds of game play 
The game play data presented here was collected in four distinct 
rounds, with each round consisting of a set of 100 boards (sets of 
25 distinct genes).  We chose gene sets for boards by first 
identifying a list of 2500 ‘interesting’ genes based on unsupervised 
analysis of a genomic dataset.  We then sampled randomly from 
this gene list to produce the boards for the game. 
 
Dataset used for rounds 1 and 2 (Sage DREAM7 challenge) 
The first two rounds corresponded to the two iterations of the 
training data provided for the Sage DREAM7 challenge (Margolin, 
et al., 2013).  In both cases Sage provided a processed subset of the 
METABRIC dataset (Curtis, et al., 2012) with information about 
gene expression, copy number variation (CNV), and clinical 
features including survival information.  We used the survival data 
to group the samples into two classes: those with less than ten-year 
survival from the point of diagnosis and those with greater than 
ten-year survival.  For these data sets we selected genes to include 
in the game based on both gene expression information and CNV 
data.  First we used the CNV information to rank the genes based 
on the sum of squares across all samples and selected the top 1000 
genes.  Next, we developed a ranking of the genes based on 
expression data as follows: 
(1) Remove probes with poor matches to genes based on the 
ReMOAT annotation data (Barbosa-Morais, et al., 2010). 
(2) Remove probe sets where the maximum expression value 
across all samples is lower than the overall median 
(3) Rank probe sets based on their variance across all samples 
 
Finally, we merged the genes selected based on CNV information 
with the expression-based ranking to produce a single table with 
2500 unique genes.   
 
Dataset used for rounds 3 and 4 (Griffith dataset) 
Rounds three and four used the meta gene expression dataset 
assembled for (Griffith, et al., 2013).  For this dataset, genes were 
selected following the same approach as described in the original 
publication (where at least 20% of samples should have intensities 
greater than the background threshold and the coefficient of 
variation is between 0.7 and 10).  Genes that passed those filters 
were then ranked based on their variance across all samples to 
produce a set of 2500 unique genes. 
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Composing boards 
In the first round, we seeded each board with one gene with a high 
ReliefF (Kononenko, 1994) value based on the combined CNV and 
expression data with all other genes selected randomly from the set 
of 2500.  (Note that players did not preferentially select the seeded 
genes.)  In the three subsequent rounds, we first created 50 boards 
by randomly sampling from the 2500.  Then we selected the 
second set of 50 boards by sampling from the genes used in the 
first 50 boards such that each gene appears in two boards per 
round.  While reducing the coverage of genes, this strategy allowed 
players to assess each gene in multiple contexts, hopefully 
allowing a fairer assessment of the gene’s overall value.  Each 
round had some overlap in terms of genes used.  In total, 3,731 
distinct genes were used in boards played in the game. 
 
Scoring hands 
Each time a gene was added to a player’s hand during a game, the 
server immediately responded with a score for the genes in their 
hand and a decision tree inferred using those genes.  This was 
accomplished using source code adapted from the Waikato 
Environment for Knowledge Analysis (WEKA) (Witten, et al., 
1999) operating in a Tomcat Web server.  We used WEKA’s 
implementation of the C4.5 decision tree induction algorithm as 
well as its code for cross-validation.  The scores were accuracy 
estimates from 10-fold cross-validation experiments and the trees 
were inferred using the provided genes and all training instances.  
Trees were constructed based on both CNV and expression data for 
round 1, and just expression data for rounds 2-4. 
 
Classifier evaluations 
We used WEKA’s default implementation of the sequential 
minimal optimization algorithm for training the SVMs used in the 
gene set analysis.  
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